Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC)
Compose a Response to This Article
Other responses
No responses have been published for this article.
